What will be Hurricane Maria’s impact on Puerto Rico's drug industry?

Sep 25, 2017
The island territory manufactures a quarter of all US exported drugs.
San Juan, Puerto Rico, on Sept. 20, after Hurricane Maria slammed into the U.S. territory.
HECTOR RETAMAL/AFP/Getty Images

Drug prices: how generics changed the game

Jul 25, 2017
Generics used to be sold out of car trunks. Then Congress got involved.
PHILIPPE HUGUEN/AFP/Getty Images

For many Haitians, street dispensaries are the only source of medicine

What’s a street dispensary? It’s “a sort of chemical Babel Tower,” according to Arnaud Robert, who reported on these Haitian pharmacies for the June 2017 issue of National Geographic. But the street vendors are not pharmacists, and their wares are not regulated. This illegal, ubiquitous medical practice can have serious consequences for the health of many […]

Is competition the solution to high drug prices?

Jun 14, 2017
A recent U.S. Supreme Court ruling supports a new class of generic drugs.
Joe Raedle/Getty Images

U.S.-Cuba relations could be big for pharmaceuticals

Jan 10, 2017
A "refreeze" could jeopardize cooperation on cancer drugs.
Cubans buy medicine in a drugstore in Havana.
STR/AFP/Getty Images

Silicon Valley's answer to brain fog

Oct 20, 2016
Why one startup thinks cognition enhancing pills are poised to take off.
 

 
FRANCK FIFE/AFP/Getty Images

For public good, not for profit.

Let’s do the numbers: the ALS Ice Bucket Challenge

Jul 27, 2016
The nonprofit marks its fundraising campaign’s 2-year anniversary with a research breakthrough.
Eric Singer, Paul Stanley and Tommy Thayer of the band KISS participates in the ALS Ice Bucket Challenge on Aug. 22, 2014 in Noblesville, Indiana.
Michael Hickey/Getty Images

New class of generics could save consumers, insurers billions. FDA is moving carefully.

Jul 13, 2016
The European Union has some 20 "biosimilar" generics on the market; the US has one.
Pre-filled syringes of  the adalimumab biosimilar.  The biosimilar is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis and ankylosing spondylitis.
SAM PANTHAKY/AFP/Getty Images

What Brexit may mean for the pharmaceutical industry

Jun 28, 2016
Drug makers are raising concerns Brexit could delay regulatory approval, slow down funding for basic research
British drug makers could face new regulations and road blocks for research as the U.K. prepares to leave the EU. 
Chris Radburn/AFP/Getty Images